Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 1651 AL 1665

[Shaking hands: is it Parkinson's disease?]

Lange R, Erbguth F.

MMW Fortschr Med. 2019 Jul;161(13):46-48. doi: 10.1007/s15006-019-0714-2.

Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease

Faust-Socher A, Duff-Canning S, Grabovsky A, Armstrong MJ, Rothberg B, Eslinger PJ, Meaney CA, Schneider RB, Tang-Wai DF, Fox SH, Zadikoff C, Kennedy N, Chou KL, Persad C, Litvan I, Mast BT, Gerstenecker AT, Weintraub S, Reginold W, Marras C.

Dement Geriatr Cogn Disord. 2019;47(4-6):187-197. doi: 10.1159/000496454. Epub 2019 Jul 17.

Metastatic prostate cancer presenting as tumour-induced osteomalacia

Layman AAK, Joshi S, Shah S.

BMJ Case Rep. 2019 Jul 16;12(7):e229434. doi: 10.1136/bcr-2019-229434.

Behavioral and Emotional Dysfunction in Parkinson's Disease

Bologna M, Merola A, Ricciardi L.

Parkinsons Dis. 2019 Jun 18;2019:1749525. doi: 10.1155/2019/1749525. eCollection 2019.

[Sleep and cognitive impairment in neurodegenerative diseases]

Yakovleva OV, Poluektov MG, Lyashenko EA, Levin OS.

Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(4. Vyp. 2):89-98. doi: 10.17116/jnevro201911904289.

Characteristics of olfactory function in a healthy geriatric population. Differences between physiological aging and pathology

Mydlikowska-Śmigórska A, Śmigórski K, Rymaszewska J.

Psychiatr Pol. 2019 Apr 30;53(2):433-446. doi: 10.12740/PP/92272. Epub 2019 Apr 30.

Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia

Ticinesi A, Nouvenne A, Cerundolo N, Catania P, Prati B, Tana C, Meschi T.

Nutrients. 2019 Jul 17;11(7):1633. doi: 10.3390/nu11071633.

Need for mechanically and ergonomically enhanced tremor-suppression orthoses for the upper limb: a systematic review

Fromme NP, Camenzind M, Riener R, Rossi RM.

J Neuroeng Rehabil. 2019 Jul 18;16(1):93. doi: 10.1186/s12984-019-0543-7.

Nicotinamide and Demographic and Disease transitions: Moderation is Best

Williams AC, Hill LJ.

Int J Tryptophan Res. 2019 Jul 3;12:1178646919855940. doi: 10.1177/1178646919855940. eCollection 2019.

Effects of glucagon-like peptide 1 receptor agonists on comorbidities in older patients with diabetes mellitus

Onoviran OF, Li D, Toombs Smith S, Raji MA.

Ther Adv Chronic Dis. 2019 Jul 12;10:2040622319862691. doi: 10.1177/2040622319862691. eCollection 2019.

Psychostimulant use and the brain

Lappin JM, Sara GE.

Addiction. 2019 Nov;114(11):2065-2077. doi: 10.1111/add.14708. Epub 2019 Jul 19.

Dopa Responsive Parkinsonism in an Early Onset Alzheimer's Disease Patient with a Presenilin 1 Mutation (A434T)

Jo H, Kim M, Park S, Park JE, Cho SH, Kim SJ, Jang H, Jung YH, Kim J, Na DL, Seo SW, Cho JW, Kim HJ.

J Alzheimers Dis. 2019;71(1):7-13. doi: 10.3233/JAD-190469.

Value of in vivo α-synuclein deposits in Parkinson's disease: A systematic review and meta-analysis

Tsukita K, Sakamaki-Tsukita H, Tanaka K, Suenaga T, Takahashi R.

Mov Disord. 2019 Oct;34(10):1452-1463. doi: 10.1002/mds.27794. Epub 2019 Jul 19.

Statins and Parkinson's: A complex interaction

Carroll CB, Wyse RKH, Grosset DG.

Mov Disord. 2019 Jul;34(7):934-935. doi: 10.1002/mds.27721.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias